Canadabis Capital Inc. Reveals Strategic Direction for 2020

About this update from Canadabis Capital, Inc.

[{"type":"text","content":"\n\n\n\nCanadabis Capital Inc. Reveals Strategic Direction for 2020\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nCALGARY, Feb. 11, 2020\n\n\n\nCALGARY, Feb. 11, 2020 /CNW/ - CanadaBis Capital Inc. (TSX-V:CANB) (\"CanadaBis\" or \"the Company\") a holder of a federal licence to cultivate, process and sell cannabis under the Cannabis Act, has announced its strategic direction and facility expansion focus for its subsidiary 1998643 AB LTD. (\"Stigma Grow\") \n\n \n \n\n \nStigma's focus is clear; they are a company committed to helping their evolving industry deliver on the promise of the highest-quality legal cannabis products. Their facility in Red Deer Alberta acts as the Company's cornerstone; providing the craft-quality plants needed to supply for all four pillars of their integrated business model.\n\"We are advantageously positioned to grow and manufacture products that will be among the highest quality and potency in the market,\" said President & CEO, Travis McIntyre. \"Stigma Grow intends to leverage the ability our own, top-quality flower, state-of-the-art technology, and the insight provided by our skilled and experienced staff, to target consumers and partner LPs that are looking for high-quality, \"bud-run\" extract product variations.\"\nStigma Extracts\nThe Company anticipates a shift in consumer behaviour from a focus on dry flower to a focus on concentrates in 2020 and beyond. To prepare for this demand, the Company has spent six months perfecting their systems and constructing a CIDI Lab to house hydrocarbon extraction processing — positioning them to bring difficult-to-produce products to market on a mass scale.\nIn addition to representing products that are in high demand, Stigma concentrate products will be some of the first available in the Canadian legal market.\nStigma's concentrates promise an extremely clean, consistent and pure form of cannabis product, and Stigma's third-party processing abilities have already captured the interest of several LPs looking for service providers capable of facilitating the expansion...

More updates from Canadabis Capital, Inc.